Quest Diagnostics Inc.DGX
Health Care · Health Care Equipment & Services · NYSE · United States · questdiagnostics.com
Quest Diagnostics Incorporated is a leading provider of diagnostic information services in the United States, headquartered in Secaucus, New Jersey. The company operates approximately 2,400 patient service centers nationwide, offering routine, non-routine, and advanced clinical testing, anatomic pathology, and other diagnostic services to physicians, hospitals, health plans, and patients.
Key ratios
Operating cash flow growth
13.4%TTM
2025
41.4%2024
4.9%2023
-26.0%
EPS growth
12.8%TTM
2025
13.8%2024
2.7%2023
-6.0%
FCF / Sales
11.7%TTM
2025
12.3%2024
9.2%2023
9.3%
Net margin
9.2%TTM
2025
9.0%2024
8.8%2023
9.2%
ROA
6.4%TTM
2025
6.2%2024
5.9%2023
6.1%
ROE
14.6%TTM
2025
14.8%2024
13.8%2023
14.6%
Revenue growth
9.9%TTM
2025
11.8%2024
6.7%2023
-6.4%
Recent news
Days After Launch, Attunio Health Expands Precision Psychiatry Infrastructure with Quest Diagnostics and Getlabs
Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing
Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026
Track DGX in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer